200 related articles for article (PubMed ID: 24157656)
1. Structure and RNA-binding properties of the type III-A CRISPR-associated protein Csm3.
Hrle A; Su AA; Ebert J; Benda C; Randau L; Conti E
RNA Biol; 2013 Nov; 10(11):1670-8. PubMed ID: 24157656
[TBL] [Abstract][Full Text] [Related]
2. Structural analyses of the CRISPR protein Csc2 reveal the RNA-binding interface of the type I-D Cas7 family.
Hrle A; Maier LK; Sharma K; Ebert J; Basquin C; Urlaub H; Marchfelder A; Conti E
RNA Biol; 2014; 11(8):1072-82. PubMed ID: 25483036
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the Csm3-Csm4 subcomplex in the type III-A CRISPR-Cas interference complex.
Numata T; Inanaga H; Sato C; Osawa T
J Mol Biol; 2015 Jan; 427(2):259-73. PubMed ID: 25451598
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the CRISPR-Cas RNA silencing Cmr complex bound to a target analog.
Osawa T; Inanaga H; Sato C; Numata T
Mol Cell; 2015 May; 58(3):418-30. PubMed ID: 25921071
[TBL] [Abstract][Full Text] [Related]
5. Structure of the archaeal Cascade subunit Csa5: relating the small subunits of CRISPR effector complexes.
Reeks J; Graham S; Anderson L; Liu H; White MF; Naismith JH
RNA Biol; 2013 May; 10(5):762-9. PubMed ID: 23846216
[TBL] [Abstract][Full Text] [Related]
6. Structure of an RNA silencing complex of the CRISPR-Cas immune system.
Spilman M; Cocozaki A; Hale C; Shao Y; Ramia N; Terns R; Terns M; Li H; Stagg S
Mol Cell; 2013 Oct; 52(1):146-52. PubMed ID: 24119404
[TBL] [Abstract][Full Text] [Related]
7. A complex of Cas proteins 5, 6, and 7 is required for the biogenesis and stability of clustered regularly interspaced short palindromic repeats (crispr)-derived rnas (crrnas) in Haloferax volcanii.
Brendel J; Stoll B; Lange SJ; Sharma K; Lenz C; Stachler AE; Maier LK; Richter H; Nickel L; Schmitz RA; Randau L; Allers T; Urlaub H; Backofen R; Marchfelder A
J Biol Chem; 2014 Mar; 289(10):7164-7177. PubMed ID: 24459147
[TBL] [Abstract][Full Text] [Related]
8. Conservation and variability in the structure and function of the Cas5d endoribonuclease in the CRISPR-mediated microbial immune system.
Koo Y; Ka D; Kim EJ; Suh N; Bae E
J Mol Biol; 2013 Oct; 425(20):3799-810. PubMed ID: 23500492
[TBL] [Abstract][Full Text] [Related]
9. Crystal Structures of Csm2 and Csm3 in the Type III-A CRISPR-Cas Effector Complex.
Takeshita D; Sato M; Inanaga H; Numata T
J Mol Biol; 2019 Feb; 431(4):748-763. PubMed ID: 30639408
[TBL] [Abstract][Full Text] [Related]
10. Three CRISPR-Cas immune effector complexes coexist in Pyrococcus furiosus.
Majumdar S; Zhao P; Pfister NT; Compton M; Olson S; Glover CV; Wells L; Graveley BR; Terns RM; Terns MP
RNA; 2015 Jun; 21(6):1147-58. PubMed ID: 25904135
[TBL] [Abstract][Full Text] [Related]
11. Genetic determinants of PAM-dependent DNA targeting and pre-crRNA processing in Sulfolobus islandicus.
Peng W; Li H; Hallstrøm S; Peng N; Liang YX; She Q
RNA Biol; 2013 May; 10(5):738-48. PubMed ID: 23392249
[TBL] [Abstract][Full Text] [Related]
12. Structure of the CRISPR interference complex CSM reveals key similarities with cascade.
Rouillon C; Zhou M; Zhang J; Politis A; Beilsten-Edmands V; Cannone G; Graham S; Robinson CV; Spagnolo L; White MF
Mol Cell; 2013 Oct; 52(1):124-34. PubMed ID: 24119402
[TBL] [Abstract][Full Text] [Related]
13. In vitro assembly and activity of an archaeal CRISPR-Cas type I-A Cascade interference complex.
Plagens A; Tripp V; Daume M; Sharma K; Klingl A; Hrle A; Conti E; Urlaub H; Randau L
Nucleic Acids Res; 2014 Apr; 42(8):5125-38. PubMed ID: 24500198
[TBL] [Abstract][Full Text] [Related]
14. RNA targeting by the type III-A CRISPR-Cas Csm complex of Thermus thermophilus.
Staals RH; Zhu Y; Taylor DW; Kornfeld JE; Sharma K; Barendregt A; Koehorst JJ; Vlot M; Neupane N; Varossieau K; Sakamoto K; Suzuki T; Dohmae N; Yokoyama S; Schaap PJ; Urlaub H; Heck AJ; Nogales E; Doudna JA; Shinkai A; van der Oost J
Mol Cell; 2014 Nov; 56(4):518-30. PubMed ID: 25457165
[TBL] [Abstract][Full Text] [Related]
15. The structure of the CRISPR-associated protein Csa3 provides insight into the regulation of the CRISPR/Cas system.
Lintner NG; Frankel KA; Tsutakawa SE; Alsbury DL; Copié V; Young MJ; Tainer JA; Lawrence CM
J Mol Biol; 2011 Jan; 405(4):939-55. PubMed ID: 21093452
[TBL] [Abstract][Full Text] [Related]
16. Cross-cleavage activity of Cas6b in crRNA processing of two different CRISPR-Cas systems in Methanosarcina mazei Gö1.
Nickel L; Ulbricht A; Alkhnbashi OS; Förstner KU; Cassidy L; Weidenbach K; Backofen R; Schmitz RA
RNA Biol; 2019 Apr; 16(4):492-503. PubMed ID: 30153081
[TBL] [Abstract][Full Text] [Related]
17. Two CRISPR-Cas systems in Methanosarcina mazei strain Gö1 display common processing features despite belonging to different types I and III.
Nickel L; Weidenbach K; Jäger D; Backofen R; Lange SJ; Heidrich N; Schmitz RA
RNA Biol; 2013 May; 10(5):779-91. PubMed ID: 23619576
[TBL] [Abstract][Full Text] [Related]
18. Type III-A CRISPR-Cas Csm Complexes: Assembly, Periodic RNA Cleavage, DNase Activity Regulation, and Autoimmunity.
Jia N; Mo CY; Wang C; Eng ET; Marraffini LA; Patel DJ
Mol Cell; 2019 Jan; 73(2):264-277.e5. PubMed ID: 30503773
[TBL] [Abstract][Full Text] [Related]
19. Fragmentation of the CRISPR-Cas Type I-B signature protein Cas8b.
Richter H; Rompf J; Wiegel J; Rau K; Randau L
Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt B):2993-3000. PubMed ID: 28238733
[TBL] [Abstract][Full Text] [Related]
20. Formation and Stoichiometry of CRISPR-Cascade Complexes with Varying Spacer Lengths Revealed by Native Mass Spectrometry.
Wittig S; Songailiene I; Schmidt C
J Am Soc Mass Spectrom; 2020 Mar; 31(3):538-546. PubMed ID: 32008319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
